Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test

European Journal of Pharmacology

Volumn 780, Issue , 2016, Pages 71-81

  Haj Mirzaian, Arya ^a,b   Kordjazy, Nastaran ^a,b   Amiri, Shayan ^a,b   Haj Mirzaian, Arvin ^a,b   Amini Khoei, Hossien ^a,b   Ostadhadi, Sattar ^a,b,c   Dehpour, AhmadReza ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

(NO cGMP); Antidepressant; Forced swimming test (FST); Nitric oxide cyclic guanosine monophosphate; Ondansetron; Tail suspension test (TST); Tropisetron

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; CYCLIC GMP; FLUOXETINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; ONDANSETRON; TROPISETRON; ANTIDEPRESSANT AGENT; INDOLE DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; FORCED SWIM TEST; HIPPOCAMPUS; LOCOMOTION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; TAIL SUSPENSION TEST; ADVERSE EFFECTS; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG EFFECTS; IMMOBILIZATION; MALE; METABOLISM; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB SUSPENSION; INDOLES; LOCOMOTION; MALE; MICE; NITRIC OXIDE; NITRITES; ONDANSETRON; SEROTONIN ANTAGONISTS; SWIMMING;

EID: 84962046533     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.03.034     Document Type: Article

References (63)

1. S. Amiri, A. Haj-Mirzaian, M. Rahimi-Balaei, A. Razmi, N. Kordjazy, A. Shirzadian, S.E. Mehr, H. Sianati, and A.R. Dehpour Co-occurrence of anxiety and depressive-like behaviors following adolescent social isolation in male mice; possible role of nitrergic system Physiol. Behav. 145 2015 38 44
2. S. Amiri, H. Amini-Khoei, A. Haj-Mirzaian, M. Rahimi-Balaei, P. Naserzadeh, A. Dehpour, S.E. Mehr, and M.-J. Hosseini Tropisetron attenuated the anxiogenic effects of social isolation by modulating nitrergic system and mitochondrial function Biochim. Biophys. Acta (BBA) - Gen. Subj. 1850 2015 2464 2475
3. B. Arroll, S. Macgillivray, S. Ogston, I. Reid, F. Sullivan, B. Williams, and I. Crombie Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis Ann. Fam. Med. 3 2005 449 456
4. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat. Rev. Neurosci. 7 2006 137 151
5. S. Bhatt, R. Mahesh, T. Devadoss, and A.K. Jindal Antidepressant-like effect of novel 5-HT3 receptor antagonist Nn-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests Indian J. Pharmacol. 45 2013 348
6. S. Blackshaw, M.J.L. Eliasson, A. Sawa, C.C. Watkins, D. Krug, A. Gupta, T. Arai, R.J. Ferrante, and S.H. Snyder Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity Neuroscience 119 2003 979 990
7. G. Bravo, and S. Maswood Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test Pharmacol. Biochem. Behav. 85 2006 362 368
8. A. Broocks Ondansetron - the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases Fortschritte der Neurologie-Psychiatrie 60 1992 227 236
9. W. Compton, K. Conway, F. Stinson, and B. Grant Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002 Am. J. Psychiatry 163 2006 2141 2147
10. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245
11. J.F. Cryan, C. Mombereau, and A. Vassout The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice Neurosci. Biobehav. Rev. 29 2005 571 625
12. G.d.L. da Silva, A.S. Matteussi, A.R.S. dos Santos, J.B. Calixto, and A.L.S. Rodrigues Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice Neuroreport 11 2000 3699 3702
13. J.W. Denninger, and M.A. Marletta Guanylate cyclase and the NO/cGMP signaling pathway Biochim. Biophys. Acta (BBA) - Bioenerg. 1411 1999 334 350
14. A. Dhir, and S. Kulkarni Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 2007 921 925
15. A.L. Eckeli, F. Dach, and A.L.S. Rodrigues Acute treatments with GMP produce antidepressant-like effects in mice Neuroreport 11 2000 1839 1843
16. J. Garthwaite, and C. Boulton Nitric oxide signaling in the central nervous system Annu. Rev. Physiol. 57 1995 683 706
17. M. Ghasemi, H. Sadeghipour, A. Mosleh, H.R. Sadeghipour, A.R. Mani, and A.R. Dehpour Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test Eur. Neuropsychopharmacol. 18 2008 323 332
18. T. Gholipour, M. Ghasemi, K. Riazi, M. Ghaffarpour, and A.R. Dehpour Seizure susceptibility alteration through 5-HT3 receptor: modulation by nitric oxide Seizure 19 2010 17 22
19. J. Giordano, and T. Schultea Serotonin 5-HT(3) receptor mediation of pain and anti-nociception: implications for clinical therapeutics Pain Physician 7 2004 141 147
20. D.L. Granger, R.R. Taintor, K.S. Boockvar, and J.B. Hibbs Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction Methods Enzymol. 268 1996 142 151
21. A.J. Greenshaw, and P.H. Silverstone The non-antiemetic uses of serotonin 5-HT3 receptor antagonists Drugs 53 1997 20 39
22. F. Guix, I. Uribesalgo, M. Coma, and F. Munoz The physiology and pathophysiology of nitric oxide in the brain Prog. Neurobiol. 76 2005 126 152
23. D. Gupta, M. Radhakrishnan, and Y. Kurhe 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system Pharmacol. Biochem. Behav. 124 2014 129 136
24. A. Haj-Mirzaian, S. Amiri, N. Kordjazy, M. Rahimi-Balaei, A. Haj-Mirzaian, H. Marzban, A. Aminzadeh, A.R. Dehpour, and S.E. Mehr Blockade of NMDA receptors reverses the depressant, but not anxiogenic effect of adolescence social isolation in mice Eur. J. Pharmacol. 750 2015 160 166
25. A. Haj-Mirzaian, N. Kordjazy, A. Haj-Mirzaian, S. Ostadhadi, M. Ghasemi, S. Amiri, M. Faizi, and A. Dehpour Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests Psychopharmacology 2015 1 11
26. A. Haj-Mirzaian, S. Ostadhadi, N. Kordjazy, A.R. Dehpour, and S. Ejtemaei Mehr Opioid/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test Eur. J. Pharmacol. 735 2014 26 31
27. A. Harkin, T.J. Connor, M.P. Burns, and J.P. Kelly Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Eur. Neuropsychopharmacol. 14 2004 274 281
28. A.J. Harkin, K.H. Bruce, B. Craft, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatments are active in the forced swim test Eur. J. Pharmacol. 372 1999 207 213
29. B.H. Harvey, F. Oosthuizen, L. Brand, G. Wegener, and D.J. Stein Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus Psychopharmacology 175 2004 494 502
30. U. Haus, B. Varga, Thomas Stratz, Michael Späth, and Wolfgang Müller Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain Scand. J. Rheumatol. 29 2000 55 58
31. I.L. Heiberg, G. Wegener, and R. Rosenberg Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats Behav. Brain Res. 134 2002 479 484
32. W.A. Hewlett, S.P. Schmid, and R.M. Salomon Pilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder J. Clin. Psychiatry 64 2003 1025 1030
33. D. Hoyer, and P. Schoeffter 5-HT receptors: subtypes and second messengers J. Recept. Signal Transduct. 11 1991 197 214
34. M. Javadi-Paydar, M. Zakeri, A. Norouzi, H. Rastegar, N. Mirazi, and A.R. Dehpour Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice Brain Res. 1429 2012 61 71
35. S.R.L. Joca, and F.S. Guimarães Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects Psychopharmacology 185 2006 298 305
36. G. Kempermann, and G. Kronenberg Depressed new neurons? - Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression Biol. Psychiatry 54 2003 499 503
37. N. Kordjazy, A. Haj-Mirzaian, S. Amiri, S. Ostadhadi, M. Kordjazy, M. Sharifzadeh, and A.R. Dehpour Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice Eur. J. Pharmacol. 762 2015 411 418
38. N. Kulesskaya, and V. Voikar Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure Physiol. Behav. 133 2014 30 38
39. Y. Kurhe, M. Radhakrishnan, D. Gupta, and T. Devadoss QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice J. Pharm. Pharmacol. 66 2014 122 132
40. Y. Lecrubier, A. Puech, A. Azcona, P. Bailey, and X. Lataste A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder Psychopharmacology 112 1993 129 133
41. C.F. Lourenço, N.R. Ferreira, R.M. Santos, N. Lukacova, R.M. Barbosa, and J. Laranjinha The pattern of glutamate-induced nitric oxide dynamics in vivo and its correlation with nNOS expression in rat hippocampus, cerebral cortex and striatum Brain Res. 1554 2014 1 11
42. R. Mahesh, A.K. Dhar, A. Jindal, and S. Bhatt Design, synthesis and evaluation of antidepressant activity of novel 2-methoxy 1, 8 naphthyridine 3-carboxamides as 5-HT3 receptor antagonists Chem. Biol. Drug Des. 83 2014 583 591
43. P. Martin, H. Gozlan, and A.J. Puech 5-HT3 receptor antagonists reverse helpless behaviour in rats Eur. J. Pharmacol. 212 1992 73 78
44. M. Moretti, A. Colla, G. de Oliveira Balen, D.B. dos Santos, J. Budni, A.E. de Freitas, M. Farina, and A.L. Severo Rodrigues Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress J. Psychiatr. Res. 46 2012 331 340
45. Y. Nakagawa, T. Ishima, and T. Takashima The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats Brain Res. 786 1998 189 193
46. S.V. Nayak, P. Ronde, A.D. Spier, S.C.R. Lummis, and R.A. Nichols Calcium changes induced by presynaptic 5-hydroxytryptamine-3 serotonin receptors on isolated terminals from various regions of the rat brain Neuroscience 91 1999 107 117
47. R. Olivenza, M.A. Moro, I. Lizasoain, P. Lorenzo, A.P. Fernández, J. Rodrigo, L. Boscá, and J.C. Leza Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex J. Neurochem. 74 2000 785 791
48. R. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Archives internationales de pharmacodynamie et de thérapie 229 1977 327
49. R. Rajkumar, and R. Mahesh Review: the auspicious role of the 5-HT3 receptor in depression: a probable neuronal target? J. Psychopharmacol. 24 2010 455 469
50. R. Ramamoorthy, M. Radhakrishnan, and M. Borah Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models Behav. Pharmacol. 19 2008 29 40
51. M.S. Sadaghiani, M. Javadi-Paydar, M.H. Gharedaghi, Y.Y. Fard, and A.R. Dehpour Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway Behav. Brain Res. 224 2011 336 343
52. A. Sahay, and R. Hen Adult hippocampal neurogenesis in depression Nat. Neurosci. 10 2007 1110 1115
53. C. Sévoz-Couche, B. Maisonneuve, M. Hamon, and R. Laguzzi Glutamate and NO mediation of the pressor response to 5-HT3 receptor stimulation in the nucleus tractus solitarii Neuroreport 13 2002 837 841
54. M.T. Silva, T.F. Galvao, S.S. Martins, and M.G. Pereira Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis Revista Brasileira de Psiquiatria 36 2014 262 270
55. A. Spiacci Jr., F. Kanamaru, and F. Guimaraes Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression Pharmacol. Biochem. Behav. 88 2008 247 255
56. J.R. Steinert, T. Chernova, and I.D. Forsythe Nitric oxide signaling in brain function, dysfunction, and dementia Neuroscientist 16 2010 435 452
57. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370
58. P.V. Turner, T. Brabb, C. Pekow, and M.A. Vasbinder Administration of substances to laboratory animals: routes of administration and factors to consider J. Am. Assoc. Lab. Anim. Sci.: JAALAS 50 2011 600
59. J.L. Warner-Schmidt, and R.S. Duman Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment Hippocampus 16 2006 239 249
60. G. Wegener, V. Volke, and R. Rosenberg Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo Br. J. Pharmacol. 130 2000 575 580
61. C.H.R. Wetzel, B. Hermann, C. Behl, E. Pestel, G. Rammes, W. Zieglgansberger, F. Holsboer, and R. Rupprecht Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor Mol. Endocrinol. 12 1998 1441 1451
62. Q.G. Zhou, Y. Hu, Y. Hua, M. Hu, C.X. Luo, X. Han, X.J. Zhu, B. Wang, J.S. Xu, and D.Y. Zhu Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis J. Neurochem. 103 2007 1843 1854
63. A.D. Zomkowski, D. Engel, N.H. Gabilan, and A.L.S. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test Eur. Neuropsychopharmacol. 20 2010 793 801